Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 3.8/5
Seegene Inc (096530 KS)
Watchlist
88
Analysis
Health Care
•
South Korea
Seegene, Inc. manufactures In Vitro Diagnostic (IVD) products mainly through molecular diagnostic method. The Company provides diagnostic & screening products for cancer, sepsis, influenza and virus infection.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
11 Mar 2024 13:23
Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener
We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...
Tina Banerjee
Follow
399 Views
Share
bearish
•
Doosan Enerbility
•
09 Jun 2025 20:10
Key Microstructure Angles to Watch as NXT Volume Caps Kick In
NextTrade (ATS) is pulling forward its timeline—trading’s getting shut off end of this month for names where NXT’s got heavy flow. A rundown of the...
Sanghyun Park
Follow
450 Views
Share
bullish
•
Cross Asset Strategy
•
24 Sep 2024 17:56
Korea Value Up Index - Surprising Inclusions and Exclusions
There are many surprising inclusions and exclusions in the Korea Value Up Index. We provide 30 companies that are surprising inclusions and 10...
Douglas Kim
Follow
1.4k Views
Share
bullish
•
Thematic (Sector/Industry)
•
04 May 2025 00:30
APAC Healthcare Weekly (May 4)- Takeda Pharma, Samsung Biologics, Celltrion, Dr. Reddy’s, Medanta
Takeda retained top slot in domestic market. Samsung Biologics signed major CDMO deal with US client. Celltrion got approval to start trial of...
Tina Banerjee
Follow
573 Views
Share
bullish
•
Thematic (Sector/Industry)
•
23 Feb 2025 00:30
APAC Healthcare Weekly (Feb 23)- Ono Pharma, Shionogi, Samsung Biologics, Celltrion, CSPC, Mayne
APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...
Tina Banerjee
Follow
569 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x